Ledger.Open graph →
SEC Form D · Amendment · filed May 18, 2015

TISSUE REGENERATION SYSTEMS INC

Offering
$4.1M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLYMOUTH, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Colleen J. Spencer · Plymouth, MIExecHenry R. Brown · Plymouth, MIDirectorWilliam J. Fitzsimmons · Seattle, WAExec · DirectorThomas E. Porter · Plymouth, MIDirectorJames R. Adox · Ann Arbor, MIDirectorWilliam L. Murphy · Plymouth, MIDirectorFrank R. Lamarca · Plymouth, MIDirectorRona Segev · Tel Aviv, L3DirectorTLV GP Partners, L.P · Tel Aviv, L3ExecEitan Bek · Tel Aviv, L3Exec · DirectorJohn A. Shimp · Charlotte, NCExec · DirectorRobert L. Edwards, Jr · Charlotte, NCDirectorEdward A. Balogh, Jr · Charlotte, NCExec · DirectorGeorge E. Morgan, Iii · Dallas, TXDirectorScott R. Poole · Charlotte, NCDirectorJohn T. Hain · Charlotte, NCDirectorJohn J. Purcell · Charlotte, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗